All subjects had at least one tumor-specific SNV, insertion, or deletion detected in baseline plasma, with a median of 10 somatic mutations that were most frequently found in lung cancer genes, including TP53, KRAS, and NPAP1 (Table S2). This evidence concerns the gene KRAS and lung cancer.